Personalised treatment reverses type 2
Researchers have used a restricted aphrodisiac to reverse type 2 diabetes in people whose condition is linked to a common genetic variant.
The treatment, yohimbine, restores the capacity to secrete insulin, which the Swedish researchers say is impaired by the variant ADRA2A.
However, the drug caused raised blood pressure among patients in a placebo-controlled trial.
Yohimbine, an a2A-adrenergic receptor antagonist, is restricted in Australia and cannot be imported without the permission of the Department of